| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transporter activity | GJA1 SLC7A1 SLC7A2 ABCA2 SLC7A3 KCNC1 SLC24A2 TSPO2 SCN7A SCN9A SLC35A1 TMEM63C LRP2 ABCB11 GABRQ SV2C ATP12A KCNK17 SLC7A7 CNGA2 UNC80 RYR2 | 1.73e-08 | 1289 | 86 | 22 | GO:0005215 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | GJA1 SLC7A1 SLC7A2 ABCA2 SLC7A3 KCNC1 SLC24A2 TSPO2 SCN7A SCN9A SLC35A1 TMEM63C ABCB11 GABRQ SV2C ATP12A KCNK17 SLC7A7 CNGA2 UNC80 RYR2 | 1.92e-08 | 1180 | 86 | 21 | GO:0022857 |
| GeneOntologyMolecularFunction | L-arginine transmembrane transporter activity | 2.23e-07 | 13 | 86 | 4 | GO:0061459 | |
| GeneOntologyMolecularFunction | L-ornithine transmembrane transporter activity | 7.67e-07 | 5 | 86 | 3 | GO:0000064 | |
| GeneOntologyMolecularFunction | basic amino acid transmembrane transporter activity | 1.47e-06 | 20 | 86 | 4 | GO:0015174 | |
| GeneOntologyMolecularFunction | L-lysine transmembrane transporter activity | 6.36e-06 | 9 | 86 | 3 | GO:0015189 | |
| GeneOntologyMolecularFunction | channel activity | GJA1 KCNC1 SLC24A2 SCN7A SCN9A TMEM63C GABRQ KCNK17 CNGA2 UNC80 RYR2 | 1.54e-05 | 525 | 86 | 11 | GO:0015267 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | GJA1 KCNC1 SLC24A2 SCN7A SCN9A TMEM63C GABRQ KCNK17 CNGA2 UNC80 RYR2 | 1.57e-05 | 526 | 86 | 11 | GO:0022803 |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 1.69e-05 | 343 | 86 | 9 | GO:0005261 | |
| GeneOntologyMolecularFunction | tRNA-4-demethylwyosine synthase activity | 1.83e-05 | 2 | 86 | 2 | GO:0102521 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | KCNC1 SLC24A2 SCN7A SCN9A TMEM63C GABRQ KCNK17 CNGA2 UNC80 RYR2 | 2.78e-05 | 459 | 86 | 10 | GO:0005216 |
| GeneOntologyMolecularFunction | organic cation transmembrane transporter activity | 2.94e-05 | 83 | 86 | 5 | GO:0015101 | |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | 3.85e-05 | 293 | 86 | 8 | GO:0008514 | |
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor activity | 4.15e-05 | 16 | 86 | 3 | GO:0005041 | |
| GeneOntologyMolecularFunction | amino acid transmembrane transporter activity | 9.07e-05 | 105 | 86 | 5 | GO:0015171 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor activity | 9.70e-05 | 21 | 86 | 3 | GO:0030228 | |
| GeneOntologyMolecularFunction | very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase activity | 1.09e-04 | 4 | 86 | 2 | GO:0102158 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | GJA1 KCNC1 SLC24A2 SCN7A SCN9A TMEM63C GABRQ ATP12A KCNK17 CNGA2 UNC80 RYR2 | 1.46e-04 | 793 | 86 | 12 | GO:0015075 |
| GeneOntologyMolecularFunction | osmolarity-sensing monoatomic cation channel activity | 1.82e-04 | 5 | 86 | 2 | GO:1990760 | |
| GeneOntologyMolecularFunction | L-amino acid transmembrane transporter activity | 2.50e-04 | 71 | 86 | 4 | GO:0015179 | |
| GeneOntologyMolecularFunction | peptidyltransferase activity | 2.72e-04 | 6 | 86 | 2 | GO:0000048 | |
| GeneOntologyMolecularFunction | osmosensor activity | 2.72e-04 | 6 | 86 | 2 | GO:0005034 | |
| GeneOntologyMolecularFunction | leukotriene-C(4) hydrolase | 2.72e-04 | 6 | 86 | 2 | GO:0002951 | |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | 2.72e-04 | 207 | 86 | 6 | GO:0046943 | |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | 2.80e-04 | 208 | 86 | 6 | GO:0005342 | |
| GeneOntologyMolecularFunction | oxo-acid-lyase activity | 3.80e-04 | 7 | 86 | 2 | GO:0016833 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a tRNA | 3.96e-04 | 144 | 86 | 5 | GO:0140101 | |
| GeneOntologyMolecularFunction | 3-hydroxyacyl-CoA dehydratase activity | 5.05e-04 | 8 | 86 | 2 | GO:0018812 | |
| GeneOntologyMolecularFunction | leukotriene C4 gamma-glutamyl transferase activity | 5.05e-04 | 8 | 86 | 2 | GO:0103068 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | KCNC1 SLC24A2 SCN7A SCN9A TMEM63C ATP12A KCNK17 CNGA2 UNC80 RYR2 | 5.62e-04 | 664 | 86 | 10 | GO:0008324 |
| GeneOntologyMolecularFunction | gated channel activity | 5.97e-04 | 334 | 86 | 7 | GO:0022836 | |
| GeneOntologyMolecularFunction | glutathione hydrolase activity | 6.47e-04 | 9 | 86 | 2 | GO:0036374 | |
| GeneOntologyMolecularFunction | potassium ion transmembrane transporter activity | 7.77e-04 | 167 | 86 | 5 | GO:0015079 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 8.83e-04 | 465 | 86 | 8 | GO:0046873 | |
| GeneOntologyMolecularFunction | enoyl-CoA hydratase activity | 1.18e-03 | 12 | 86 | 2 | GO:0004300 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | 1.50e-03 | 627 | 86 | 9 | GO:0022890 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | KCNC1 SLC24A2 SCN7A SCN9A TMEM63C GABRQ ATP12A KCNK17 CNGA2 RYR2 | 1.53e-03 | 758 | 86 | 10 | GO:0015318 |
| GeneOntologyMolecularFunction | omega peptidase activity | 2.12e-03 | 16 | 86 | 2 | GO:0008242 | |
| GeneOntologyMolecularFunction | FMN binding | 2.12e-03 | 16 | 86 | 2 | GO:0010181 | |
| GeneOntologyMolecularFunction | lyase activity | 2.23e-03 | 212 | 86 | 5 | GO:0016829 | |
| GeneOntologyMolecularFunction | hydro-lyase activity | 2.54e-03 | 63 | 86 | 3 | GO:0016836 | |
| GeneOntologyMolecularFunction | threonine-type peptidase activity | 3.31e-03 | 20 | 86 | 2 | GO:0070003 | |
| GeneOntologyMolecularFunction | iron-sulfur cluster binding | 4.65e-03 | 78 | 86 | 3 | GO:0051536 | |
| GeneOntologyMolecularFunction | carbon-oxygen lyase activity | 5.35e-03 | 82 | 86 | 3 | GO:0016835 | |
| GeneOntologyMolecularFunction | metal cluster binding | 5.53e-03 | 83 | 86 | 3 | GO:0051540 | |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 5.57e-03 | 26 | 86 | 2 | GO:0005248 | |
| GeneOntologyMolecularFunction | oxidoreductase activity | 5.66e-03 | 766 | 86 | 9 | GO:0016491 | |
| GeneOntologyMolecularFunction | cargo receptor activity | 5.91e-03 | 85 | 86 | 3 | GO:0038024 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 6.39e-03 | 171 | 86 | 4 | GO:0015081 | |
| GeneOntologyMolecularFunction | histone kinase activity | 6.44e-03 | 28 | 86 | 2 | GO:0035173 | |
| GeneOntologyBiologicalProcess | vascular transport | 8.26e-08 | 88 | 86 | 7 | GO:0010232 | |
| GeneOntologyBiologicalProcess | L-arginine transmembrane transport | 3.71e-07 | 15 | 86 | 4 | GO:1903826 | |
| GeneOntologyBiologicalProcess | basic amino acid transmembrane transport | 1.04e-06 | 19 | 86 | 4 | GO:1990822 | |
| GeneOntologyBiologicalProcess | L-ornithine transmembrane transport | 1.39e-06 | 6 | 86 | 3 | GO:1903352 | |
| GeneOntologyBiologicalProcess | transport across blood-brain barrier | 1.70e-06 | 87 | 86 | 6 | GO:0150104 | |
| GeneOntologyBiologicalProcess | basic amino acid transport | 1.95e-06 | 22 | 86 | 4 | GO:0015802 | |
| GeneOntologyBiologicalProcess | ornithine transport | 2.42e-06 | 7 | 86 | 3 | GO:0015822 | |
| GeneOntologyBiologicalProcess | L-arginine import across plasma membrane | 3.86e-06 | 8 | 86 | 3 | GO:0097638 | |
| GeneOntologyBiologicalProcess | monoatomic cation transport | SLC35G1 GJA1 ZMPSTE24 MCHR1 KCNC1 SLC24A2 SCN7A SCN9A TSPAN13 TMEM63C LRP2 SPG11 ATP12A KCNK17 CNGA2 UNC80 RYR2 | 4.83e-06 | 1157 | 86 | 17 | GO:0006812 |
| GeneOntologyBiologicalProcess | L-lysine transmembrane transport | 8.22e-06 | 10 | 86 | 3 | GO:1903401 | |
| GeneOntologyBiologicalProcess | L-lysine transport | 8.22e-06 | 10 | 86 | 3 | GO:1902022 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | SLC35G1 GJA1 ZMPSTE24 MCHR1 KCNC1 SLC24A2 SCN7A SCN9A TSPAN13 TMEM63C LRP2 GABRQ SPG11 ATP12A KCNK17 CNGA2 UNC80 RYR2 | 1.18e-05 | 1374 | 86 | 18 | GO:0006811 |
| GeneOntologyBiologicalProcess | metal ion transport | SLC35G1 GJA1 ZMPSTE24 MCHR1 KCNC1 SLC24A2 SCN7A SCN9A TSPAN13 LRP2 SPG11 ATP12A KCNK17 CNGA2 RYR2 | 1.49e-05 | 1000 | 86 | 15 | GO:0030001 |
| GeneOntologyBiologicalProcess | import across plasma membrane | 4.98e-05 | 230 | 86 | 7 | GO:0098739 | |
| GeneOntologyBiologicalProcess | lysine transport | 5.14e-05 | 3 | 86 | 2 | GO:0015819 | |
| GeneOntologyBiologicalProcess | carboxylic acid transmembrane transport | 6.20e-05 | 163 | 86 | 6 | GO:1905039 | |
| GeneOntologyBiologicalProcess | organic acid transmembrane transport | 7.09e-05 | 167 | 86 | 6 | GO:1903825 | |
| GeneOntologyBiologicalProcess | amino acid import across plasma membrane | 1.01e-04 | 58 | 86 | 4 | GO:0089718 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential involved in contraction | 1.31e-04 | 62 | 86 | 4 | GO:0086002 | |
| GeneOntologyBiologicalProcess | amino acid transmembrane transport | 1.47e-04 | 120 | 86 | 5 | GO:0003333 | |
| GeneOntologyBiologicalProcess | amino acid transport | 1.66e-04 | 195 | 86 | 6 | GO:0006865 | |
| GeneOntologyBiologicalProcess | positive regulation of lysosomal protein catabolic process | 1.70e-04 | 5 | 86 | 2 | GO:1905167 | |
| GeneOntologyBiologicalProcess | chemoattraction of axon | 1.70e-04 | 5 | 86 | 2 | GO:0061642 | |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | SLC35G1 GJA1 KCNC1 SLC24A2 SCN7A SCN9A TSPAN13 TMEM63C GABRQ ATP12A KCNK17 CNGA2 UNC80 RYR2 | 1.98e-04 | 1115 | 86 | 14 | GO:0034220 |
| GeneOntologyBiologicalProcess | circulatory system process | GJA1 SLC7A1 SLC7A2 ABCA2 SLC7A3 ZMPSTE24 SCN7A SCN9A LRP1 LRP2 RYR2 | 2.29e-04 | 733 | 86 | 11 | GO:0003013 |
| GeneOntologyBiologicalProcess | wybutosine metabolic process | 2.55e-04 | 6 | 86 | 2 | GO:0031590 | |
| GeneOntologyBiologicalProcess | wybutosine biosynthetic process | 2.55e-04 | 6 | 86 | 2 | GO:0031591 | |
| GeneOntologyBiologicalProcess | calcium ion transport | SLC35G1 GJA1 ZMPSTE24 MCHR1 SLC24A2 TSPAN13 SPG11 CNGA2 RYR2 | 2.70e-04 | 509 | 86 | 9 | GO:0006816 |
| GeneOntologyBiologicalProcess | organic anion transport | 2.94e-04 | 515 | 86 | 9 | GO:0015711 | |
| GeneOntologyBiologicalProcess | carboxylic acid transport | 3.12e-04 | 410 | 86 | 8 | GO:0046942 | |
| GeneOntologyBiologicalProcess | organic acid transport | 3.23e-04 | 412 | 86 | 8 | GO:0015849 | |
| GeneOntologyBiologicalProcess | organic cation transport | 3.53e-04 | 145 | 86 | 5 | GO:0015695 | |
| GeneOntologyBiologicalProcess | positive regulation of protein catabolic process in the vacuole | 3.56e-04 | 7 | 86 | 2 | GO:1904352 | |
| GeneOntologyBiologicalProcess | membrane lipid metabolic process | 3.93e-04 | 229 | 86 | 6 | GO:0006643 | |
| GeneOntologyBiologicalProcess | cysteine biosynthetic process | 4.73e-04 | 8 | 86 | 2 | GO:0019344 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential | 4.82e-04 | 87 | 86 | 4 | GO:0086001 | |
| GeneOntologyBiologicalProcess | L-alpha-amino acid transmembrane transport | 4.82e-04 | 87 | 86 | 4 | GO:1902475 | |
| GeneOntologyBiologicalProcess | small molecule biosynthetic process | ABCA2 VKORC1 HACD3 ABCB11 FADS2 ALOXE3 GPRC6A HACD2 GGT2P GGT1 | 5.03e-04 | 676 | 86 | 10 | GO:0044283 |
| GeneOntologyBiologicalProcess | membrane lipid biosynthetic process | 5.08e-04 | 157 | 86 | 5 | GO:0046467 | |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | SLC35G1 KCNC1 SLC24A2 SCN7A SCN9A TSPAN13 TMEM63C ATP12A KCNK17 CNGA2 UNC80 RYR2 | 5.21e-04 | 942 | 86 | 12 | GO:0098655 |
| GeneOntologyBiologicalProcess | regulation of membrane potential | 5.33e-04 | 559 | 86 | 9 | GO:0042391 | |
| GeneOntologyBiologicalProcess | lipid biosynthetic process | ABCA2 MTMR14 HACD3 ABCB11 FADS2 ALOXE3 GPRC6A HACD2 DPM2 GGT2P GGT1 | 5.51e-04 | 813 | 86 | 11 | GO:0008610 |
| GeneOntologyBiologicalProcess | vascular process in circulatory system | 5.87e-04 | 344 | 86 | 7 | GO:0003018 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell contraction | 6.20e-04 | 93 | 86 | 4 | GO:0086003 | |
| GeneOntologyBiologicalProcess | peptide modification | 7.57e-04 | 10 | 86 | 2 | GO:0031179 | |
| GeneOntologyBiologicalProcess | leukotriene D4 biosynthetic process | 7.57e-04 | 10 | 86 | 2 | GO:1901750 | |
| GeneOntologyBiologicalProcess | sphingolipid metabolic process | 8.52e-04 | 176 | 86 | 5 | GO:0006665 | |
| GeneOntologyBiologicalProcess | glutathione catabolic process | 9.22e-04 | 11 | 86 | 2 | GO:0006751 | |
| GeneOntologyBiologicalProcess | vitamin K metabolic process | 9.22e-04 | 11 | 86 | 2 | GO:0042373 | |
| GeneOntologyBiologicalProcess | CAMKK-AMPK signaling cascade | 9.22e-04 | 11 | 86 | 2 | GO:0061762 | |
| GeneOntologyBiologicalProcess | carboxylic acid biosynthetic process | 9.59e-04 | 374 | 86 | 7 | GO:0046394 | |
| GeneOntologyBiologicalProcess | organic acid biosynthetic process | 1.00e-03 | 377 | 86 | 7 | GO:0016053 | |
| GeneOntologyBiologicalProcess | L-amino acid transport | 1.09e-03 | 108 | 86 | 4 | GO:0015807 | |
| GeneOntologyBiologicalProcess | regulation of lysosomal protein catabolic process | 1.10e-03 | 12 | 86 | 2 | GO:1905165 | |
| GeneOntologyBiologicalProcess | leukotriene D4 metabolic process | 1.10e-03 | 12 | 86 | 2 | GO:1901748 | |
| GeneOntologyCellularComponent | transmembrane transporter complex | ABCA2 KCNC1 SCN7A SCN9A GABRQ UQCRQ ATP12A KCNK17 CNGA2 UNC80 RYR2 | 8.68e-06 | 523 | 85 | 11 | GO:1902495 |
| GeneOntologyCellularComponent | transporter complex | ABCA2 KCNC1 SCN7A SCN9A GABRQ UQCRQ ATP12A KCNK17 CNGA2 UNC80 RYR2 | 1.39e-05 | 550 | 85 | 11 | GO:1990351 |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | KDELR3 SLC35G1 GJA1 VKORC1 ZMPSTE24 RNF103 HACD3 REEP6 TSPO2 CLN6 FADS2 UNC93B1 HACD2 TNPO3 DPM2 RYR2 | 7.76e-05 | 1327 | 85 | 16 | GO:0042175 |
| GeneOntologyCellularComponent | monoatomic ion channel complex | 1.52e-04 | 378 | 85 | 8 | GO:0034702 | |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | KDELR3 SLC35G1 GJA1 VKORC1 ZMPSTE24 RNF103 HACD3 REEP6 TSPO2 CLN6 FADS2 UNC93B1 HACD2 DPM2 RYR2 | 2.05e-04 | 1293 | 85 | 15 | GO:0005789 |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | KDELR3 SLC35G1 GJA1 VKORC1 ZMPSTE24 RNF103 HACD3 REEP6 TSPO2 CLN6 FADS2 UNC93B1 HACD2 DPM2 RYR2 | 2.15e-04 | 1299 | 85 | 15 | GO:0098827 |
| GeneOntologyCellularComponent | sodium channel complex | 2.20e-04 | 29 | 85 | 3 | GO:0034706 | |
| GeneOntologyCellularComponent | membrane protein complex | JAK2 GJA1 ABCA2 KCNC1 SCN7A SCN9A LRP1 GABRQ NOX3 UQCRQ ATP12A KCNK17 CNGA2 DPM2 UNC80 RYR2 | 3.13e-04 | 1498 | 85 | 16 | GO:0098796 |
| GeneOntologyCellularComponent | cation channel complex | 3.95e-04 | 235 | 85 | 6 | GO:0034703 | |
| GeneOntologyCellularComponent | ciliary membrane | 6.88e-04 | 98 | 85 | 4 | GO:0060170 | |
| GeneOntologyCellularComponent | basolateral plasma membrane | 1.95e-03 | 320 | 85 | 6 | GO:0016323 | |
| GeneOntologyCellularComponent | Golgi-associated vesicle membrane | 1.97e-03 | 61 | 85 | 3 | GO:0030660 | |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 2.14e-03 | 17 | 85 | 2 | GO:0001518 | |
| MousePheno | aminoaciduria | 1.64e-05 | 29 | 75 | 4 | MP:0003311 | |
| MousePheno | increased urine microglobulin level | 8.49e-05 | 3 | 75 | 2 | MP:0011555 | |
| MousePheno | increased circulating growth hormone level | 1.35e-04 | 19 | 75 | 3 | MP:0005123 | |
| MousePheno | aciduria | 2.12e-04 | 55 | 75 | 4 | MP:0010028 | |
| MousePheno | small vertebrae | 2.12e-04 | 22 | 75 | 3 | MP:0004610 | |
| MousePheno | increased growth hormone level | 2.43e-04 | 23 | 75 | 3 | MP:0005137 | |
| MousePheno | abnormal urine amino acid level | 2.78e-04 | 59 | 75 | 4 | MP:0011468 | |
| MousePheno | impaired stratum corneum desquamation | 2.81e-04 | 5 | 75 | 2 | MP:0009597 | |
| MousePheno | abnormal circulating glutathione level | 2.81e-04 | 5 | 75 | 2 | MP:0030652 | |
| MousePheno | increased circulating glutathione level | 2.81e-04 | 5 | 75 | 2 | MP:0030653 | |
| MousePheno | glutathionuria | 2.81e-04 | 5 | 75 | 2 | MP:0013730 | |
| MousePheno | increased glutathione level | 2.81e-04 | 5 | 75 | 2 | MP:0012606 | |
| MousePheno | abnormal spleen red pulp morphology | 3.07e-04 | 110 | 75 | 5 | MP:0002356 | |
| MousePheno | impaired ovarian folliculogenesis | 3.16e-04 | 61 | 75 | 4 | MP:0001129 | |
| Domain | Cat_AA_permease | 9.10e-08 | 3 | 85 | 3 | IPR004755 | |
| Domain | AA_permease_2 | 2.77e-07 | 13 | 85 | 4 | PF13520 | |
| Domain | AA/rel_permease1 | 2.77e-07 | 13 | 85 | 4 | IPR002293 | |
| Domain | CAT3 | 9.04e-07 | 5 | 85 | 3 | IPR015606 | |
| Domain | AA_permease_C | 9.04e-07 | 5 | 85 | 3 | PF13906 | |
| Domain | CAT_C | 9.04e-07 | 5 | 85 | 3 | IPR029485 | |
| Domain | AA-permease/SLC12A_dom | 2.75e-06 | 22 | 85 | 4 | IPR004841 | |
| Domain | AA_permease | 2.75e-06 | 22 | 85 | 4 | PF00324 | |
| Domain | Flavoprotein-like_dom | 1.07e-05 | 10 | 85 | 3 | IPR029039 | |
| Domain | - | 1.07e-05 | 10 | 85 | 3 | 3.40.50.360 | |
| Domain | DUF5050 | 2.05e-05 | 2 | 85 | 2 | IPR032485 | |
| Domain | tRNA_wybutosine-synth | 2.05e-05 | 2 | 85 | 2 | IPR013917 | |
| Domain | DUF5050 | 2.05e-05 | 2 | 85 | 2 | PF16472 | |
| Domain | Wyosine_form | 2.05e-05 | 2 | 85 | 2 | PF08608 | |
| Domain | Ldl_recept_b | 3.19e-05 | 14 | 85 | 3 | PF00058 | |
| Domain | LDLRB | 3.19e-05 | 14 | 85 | 3 | PS51120 | |
| Domain | LDLR_class-A_CS | 3.22e-05 | 40 | 85 | 4 | IPR023415 | |
| Domain | LY | 3.98e-05 | 15 | 85 | 3 | SM00135 | |
| Domain | LDLR_classB_rpt | 3.98e-05 | 15 | 85 | 3 | IPR000033 | |
| Domain | Ldl_recept_a | 5.16e-05 | 45 | 85 | 4 | PF00057 | |
| Domain | - | 5.64e-05 | 46 | 85 | 4 | 4.10.400.10 | |
| Domain | LDLRA_1 | 6.67e-05 | 48 | 85 | 4 | PS01209 | |
| Domain | LDLRA_2 | 7.24e-05 | 49 | 85 | 4 | PS50068 | |
| Domain | LDrepeatLR_classA_rpt | 7.24e-05 | 49 | 85 | 4 | IPR002172 | |
| Domain | LDLa | 7.24e-05 | 49 | 85 | 4 | SM00192 | |
| Domain | Tyr_Pase-like_PTPLA | 1.22e-04 | 4 | 85 | 2 | IPR007482 | |
| Domain | PTPLA | 1.22e-04 | 4 | 85 | 2 | PF04387 | |
| Domain | Ion_trans_dom | 1.72e-04 | 114 | 85 | 5 | IPR005821 | |
| Domain | Ion_trans | 1.72e-04 | 114 | 85 | 5 | PF00520 | |
| Domain | cEGF | 2.19e-04 | 26 | 85 | 3 | IPR026823 | |
| Domain | cEGF | 2.19e-04 | 26 | 85 | 3 | PF12662 | |
| Domain | FLAVODOXIN_LIKE | 5.63e-04 | 8 | 85 | 2 | PS50902 | |
| Domain | Flavodoxin/NO_synth | 5.63e-04 | 8 | 85 | 2 | IPR008254 | |
| Domain | Flavdoxin-like | 5.63e-04 | 8 | 85 | 2 | IPR001094 | |
| Domain | Flavodoxin_1 | 5.63e-04 | 8 | 85 | 2 | PF00258 | |
| Domain | rSAM | 7.22e-04 | 9 | 85 | 2 | IPR007197 | |
| Domain | Radical_SAM | 7.22e-04 | 9 | 85 | 2 | PF04055 | |
| Domain | - | 7.39e-04 | 39 | 85 | 3 | 2.120.10.30 | |
| Domain | Na_channel_asu | 9.00e-04 | 10 | 85 | 2 | IPR001696 | |
| Domain | Na_trans_assoc | 9.00e-04 | 10 | 85 | 2 | IPR010526 | |
| Domain | Na_trans_assoc | 9.00e-04 | 10 | 85 | 2 | PF06512 | |
| Domain | 6-blade_b-propeller_TolB-like | 1.20e-03 | 46 | 85 | 3 | IPR011042 | |
| Domain | Channel_four-helix_dom | 2.23e-03 | 57 | 85 | 3 | IPR027359 | |
| Domain | - | 2.23e-03 | 57 | 85 | 3 | 1.20.120.350 | |
| Domain | EGF_CA | 7.10e-03 | 86 | 85 | 3 | PF07645 | |
| Pathway | REACTOME_AMINO_ACID_TRANSPORT_ACROSS_THE_PLASMA_MEMBRANE | 1.62e-05 | 33 | 66 | 4 | M188 | |
| Pathway | REACTOME_FATTY_ACID_METABOLISM | 1.41e-04 | 170 | 66 | 6 | MM15573 | |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | 1.48e-04 | 108 | 66 | 5 | M823 | |
| Pathway | WP_OXYLIPINS_PATHWAYS | 1.85e-04 | 24 | 66 | 3 | MM17249 | |
| Pubmed | 9.69e-09 | 105 | 88 | 7 | 30280653 | ||
| Pubmed | 1.57e-08 | 3 | 88 | 3 | 22870827 | ||
| Pubmed | 1.57e-08 | 3 | 88 | 3 | 9334265 | ||
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | JAK2 GJA1 ZMPSTE24 TM9SF1 SLC35A1 FADS2 SPG11 TYW1 PRKDC UNC93B1 HACD2 ATP12A ALDH5A1 UNC50 GGT1 | 6.63e-08 | 1061 | 88 | 15 | 33845483 |
| Pubmed | 2.19e-07 | 52 | 88 | 5 | 26590417 | ||
| Pubmed | Genome-wide association study identifies loci influencing concentrations of liver enzymes in plasma. | 8.50e-07 | 68 | 88 | 5 | 22001757 | |
| Pubmed | Amino acid transport across mammalian intestinal and renal epithelia. | 1.14e-06 | 31 | 88 | 4 | 18195088 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | KDELR3 GJA1 ABCA2 ZMPSTE24 HACD3 TM9SF1 SLC35A1 LRP1 CLN6 FADS2 TYW1 UNC93B1 HACD2 LRP1B | 1.89e-06 | 1201 | 88 | 14 | 35696571 |
| Pubmed | 2.55e-06 | 11 | 88 | 3 | 24639464 | ||
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | GJA1 SLC7A1 VKORC1 HACD3 MARS1 TM9SF1 UQCRQ NUP214 QRICH1 PRKDC HACD2 TNPO3 | 4.52e-06 | 942 | 88 | 12 | 31073040 |
| Pubmed | 5.58e-06 | 14 | 88 | 3 | 15082773 | ||
| Pubmed | Striking differences of LDL receptor-related protein 1B expression in mouse and human. | 6.33e-06 | 2 | 88 | 2 | 15963947 | |
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 25180444 | ||
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 28684763 | ||
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 25280803 | ||
| Pubmed | The importance of cationic amino acid transporter expression in human skin. | 6.33e-06 | 2 | 88 | 2 | 12787129 | |
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 17008472 | ||
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 9174363 | ||
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 8195186 | ||
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 10556425 | ||
| Pubmed | Behavior of CD34+ cells isolated from patients with polycythemia vera in NOD/SCID mice. | 6.33e-06 | 2 | 88 | 2 | 17764815 | |
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 34445520 | ||
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 9614060 | ||
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 16162496 | ||
| Pubmed | Human cationic amino acid transporters are not affected by direct nitros(yl)ation. | 6.33e-06 | 2 | 88 | 2 | 32008093 | |
| Pubmed | Identification of a low affinity, high capacity transporter of cationic amino acids in mouse liver. | 6.33e-06 | 2 | 88 | 2 | 8385111 | |
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 26316108 | ||
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 27799555 | ||
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 37904480 | ||
| Pubmed | Regulation of cationic amino acid transporter (CAT) gene expression. | 6.33e-06 | 2 | 88 | 2 | 8878860 | |
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 15064952 | ||
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 23682772 | ||
| Pubmed | RyR2 regulates Cx43 hemichannel intracellular Ca2+-dependent activation in cardiomyocytes. | 6.33e-06 | 2 | 88 | 2 | 31841141 | |
| Pubmed | Human cationic amino acid transporter hCAT-3 is preferentially expressed in peripheral tissues. | 6.33e-06 | 2 | 88 | 2 | 11591158 | |
| Pubmed | Characterization of cationic amino acid transporters (hCATs) 1 and 2 in human skin. | 6.33e-06 | 2 | 88 | 2 | 18172665 | |
| Pubmed | Discovery and refinement of loci associated with lipid levels. | 1.66e-05 | 211 | 88 | 6 | 24097068 | |
| Pubmed | 1.90e-05 | 3 | 88 | 2 | 29776386 | ||
| Pubmed | 1.90e-05 | 3 | 88 | 2 | 32017785 | ||
| Pubmed | 1.90e-05 | 3 | 88 | 2 | 21800014 | ||
| Pubmed | Interplay between paracrine signaling and gap junctional communication in ovarian follicles. | 1.90e-05 | 3 | 88 | 2 | 15585573 | |
| Pubmed | 1.90e-05 | 3 | 88 | 2 | 21264353 | ||
| Pubmed | Factors influencing warfarin dose requirements in African-Americans. | 1.90e-05 | 3 | 88 | 2 | 18034618 | |
| Pubmed | 1.90e-05 | 3 | 88 | 2 | 20193673 | ||
| Pubmed | 1.90e-05 | 3 | 88 | 2 | 32713021 | ||
| Pubmed | 1.90e-05 | 3 | 88 | 2 | 15631944 | ||
| Pubmed | 1.90e-05 | 3 | 88 | 2 | 11665818 | ||
| Pubmed | Jak2-mediated phosphorylation of Atoh1 is critical for medulloblastoma growth. | 1.90e-05 | 3 | 88 | 2 | 29168692 | |
| Pubmed | Different gamma-glutamyl transpeptidase mRNAs are expressed in human liver and kidney. | 1.90e-05 | 3 | 88 | 2 | 2573352 | |
| Pubmed | MESD is essential for apical localization of megalin/LRP2 in the visceral endoderm. | 2.01e-05 | 21 | 88 | 3 | 21337463 | |
| Pubmed | 3.79e-05 | 4 | 88 | 2 | 12413896 | ||
| Pubmed | 3.79e-05 | 4 | 88 | 2 | 10198179 | ||
| Pubmed | 3.79e-05 | 4 | 88 | 2 | 19885591 | ||
| Pubmed | 3.79e-05 | 4 | 88 | 2 | 7775583 | ||
| Pubmed | 3.79e-05 | 4 | 88 | 2 | 18554506 | ||
| Pubmed | 3.79e-05 | 4 | 88 | 2 | 19652895 | ||
| Pubmed | 3.79e-05 | 4 | 88 | 2 | 11421580 | ||
| Pubmed | 3.79e-05 | 4 | 88 | 2 | 27357826 | ||
| Pubmed | Ribonucleome analysis identified enzyme genes responsible for wybutosine synthesis. | 3.79e-05 | 4 | 88 | 2 | 17150819 | |
| Pubmed | Interpreting cancer genomes using systematic host network perturbations by tumour virus proteins. | 4.00e-05 | 499 | 88 | 8 | 22810586 | |
| Pubmed | 6.30e-05 | 5 | 88 | 2 | 23615310 | ||
| Pubmed | 6.30e-05 | 5 | 88 | 2 | 11003618 | ||
| Pubmed | 6.30e-05 | 5 | 88 | 2 | 10392451 | ||
| Pubmed | 6.30e-05 | 5 | 88 | 2 | 19850887 | ||
| Pubmed | Reversible skeletal abnormalities in gamma-glutamyl transpeptidase-deficient mice. | 6.30e-05 | 5 | 88 | 2 | 12810527 | |
| Pubmed | Growth retardation and cysteine deficiency in gamma-glutamyl transpeptidase-deficient mice. | 6.30e-05 | 5 | 88 | 2 | 8755578 | |
| Pubmed | Reproductive defects in gamma-glutamyl transpeptidase-deficient mice. | 6.30e-05 | 5 | 88 | 2 | 11089562 | |
| Pubmed | 6.30e-05 | 5 | 88 | 2 | 26977590 | ||
| Pubmed | Gamma-glutamyl transferase deficiency results in lung oxidant stress in normoxia. | 6.30e-05 | 5 | 88 | 2 | 12225953 | |
| Pubmed | 6.30e-05 | 5 | 88 | 2 | 7775425 | ||
| Pubmed | 6.30e-05 | 5 | 88 | 2 | 9139708 | ||
| Pubmed | 6.30e-05 | 5 | 88 | 2 | 20622017 | ||
| Pubmed | Accelerated methylmercury elimination in gamma-glutamyl transpeptidase-deficient mice. | 6.30e-05 | 5 | 88 | 2 | 9546365 | |
| Pubmed | 6.30e-05 | 5 | 88 | 2 | 7485380 | ||
| Pubmed | Accumulation of DNA damage in the organs of mice deficient in gamma-glutamyltranspeptidase. | 6.30e-05 | 5 | 88 | 2 | 10751614 | |
| Pubmed | Type VI RNA is the major gamma-glutamyl transpeptidase RNA in the mouse small intestine. | 6.30e-05 | 5 | 88 | 2 | 7523374 | |
| Pubmed | Cardio-reno-hepatic interactions in acute heart failure: the role of γ-glutamyl transferase. | 6.30e-05 | 5 | 88 | 2 | 24698228 | |
| Pubmed | 6.30e-05 | 5 | 88 | 2 | 19047013 | ||
| Pubmed | 6.30e-05 | 5 | 88 | 2 | 10474818 | ||
| Pubmed | 6.30e-05 | 5 | 88 | 2 | 18685438 | ||
| Pubmed | Lung lining fluid glutathione attenuates IL-13-induced asthma. | 6.30e-05 | 5 | 88 | 2 | 18063838 | |
| Pubmed | 6.30e-05 | 5 | 88 | 2 | 10940879 | ||
| Pubmed | Cataract development in gamma-glutamyl transpeptidase-deficient mice. | 6.30e-05 | 5 | 88 | 2 | 11095909 | |
| Pubmed | 6.30e-05 | 5 | 88 | 2 | 16101684 | ||
| Pubmed | 6.30e-05 | 5 | 88 | 2 | 7641802 | ||
| Pubmed | 6.30e-05 | 5 | 88 | 2 | 23009292 | ||
| Pubmed | 6.30e-05 | 5 | 88 | 2 | 9627710 | ||
| Pubmed | 6.30e-05 | 5 | 88 | 2 | 12453183 | ||
| Pubmed | 6.30e-05 | 5 | 88 | 2 | 2891746 | ||
| Pubmed | Y+ and y+ L arginine transporters in neuronal cells expressing tyrosine hydroxylase. | 6.30e-05 | 5 | 88 | 2 | 16085056 | |
| Pubmed | 6.30e-05 | 5 | 88 | 2 | 28660214 | ||
| Pubmed | Bleomycin-induced pulmonary fibrosis is attenuated in gamma-glutamyl transpeptidase-deficient mice. | 6.30e-05 | 5 | 88 | 2 | 12468440 | |
| Pubmed | Cloning of cDNA and genomic structure of the mouse gamma-glutamyl transpeptidase-encoding gene. | 6.30e-05 | 5 | 88 | 2 | 8566783 | |
| Pubmed | 6.30e-05 | 5 | 88 | 2 | 30591459 | ||
| Pubmed | Ku proteins function as corepressors to regulate farnesoid X receptor-mediated gene expression. | 6.30e-05 | 5 | 88 | 2 | 19833092 | |
| Pubmed | 6.30e-05 | 5 | 88 | 2 | 11795900 | ||
| Pubmed | Inhibiting lung lining fluid glutathione metabolism with GGsTop as a novel treatment for asthma. | 6.30e-05 | 5 | 88 | 2 | 25132819 | |
| Pubmed | Characterization of the dwg mutations: dwg and dwg(Bayer) are new mutant alleles of the Ggt1 gene. | 6.30e-05 | 5 | 88 | 2 | 19760322 | |
| Pubmed | TGFβR-SMAD3 Signaling Induces Resistance to PARP Inhibitors in the Bone Marrow Microenvironment. | 6.30e-05 | 5 | 88 | 2 | 33027668 | |
| Pubmed | 8.85e-05 | 34 | 88 | 3 | 35341793 | ||
| Pubmed | 9.43e-05 | 6 | 88 | 2 | 14634009 | ||
| Interaction | GPR182 interactions | KDELR3 GJA1 SLC7A1 SLC7A2 ABCA2 DYM TM9SF1 CLN6 SPG11 TYW1 PRKDC UNC93B1 HACD2 ATP12A TNPO3 | 5.72e-10 | 455 | 84 | 15 | int:GPR182 |
| Interaction | VIPR1 interactions | KDELR3 SLC7A1 SLC7A2 DYM REEP6 TM9SF1 CLN6 UNC93B1 HACD2 ATP12A TNPO3 | 8.96e-10 | 205 | 84 | 11 | int:VIPR1 |
| Interaction | OPALIN interactions | 2.19e-07 | 209 | 84 | 9 | int:OPALIN | |
| Interaction | FPR2 interactions | 1.77e-06 | 138 | 84 | 7 | int:FPR2 | |
| Interaction | GPR17 interactions | 2.74e-06 | 283 | 84 | 9 | int:GPR17 | |
| Interaction | CD53 interactions | 3.60e-06 | 99 | 84 | 6 | int:CD53 | |
| Interaction | C5AR1 interactions | 3.67e-06 | 154 | 84 | 7 | int:C5AR1 | |
| Interaction | SPPL2B interactions | 5.80e-06 | 233 | 84 | 8 | int:SPPL2B | |
| Interaction | SLC2A5 interactions | 6.16e-06 | 29 | 84 | 4 | int:SLC2A5 | |
| Interaction | SEC62 interactions | SLC7A1 SLC7A2 SLC7A3 ZMPSTE24 HACD3 VANGL1 LRP2 FADS2 TYW1 UNC93B1 ATP12A | 7.97e-06 | 506 | 84 | 11 | int:SEC62 |
| Interaction | MLNR interactions | 9.46e-06 | 68 | 84 | 5 | int:MLNR | |
| Interaction | F2RL1 interactions | 1.10e-05 | 182 | 84 | 7 | int:F2RL1 | |
| Interaction | TPST2 interactions | 1.32e-05 | 124 | 84 | 6 | int:TPST2 | |
| Interaction | VIPR2 interactions | 1.67e-05 | 194 | 84 | 7 | int:VIPR2 | |
| Interaction | KCNK17 interactions | 1.72e-05 | 2 | 84 | 2 | int:KCNK17 | |
| Interaction | FPR1 interactions | 3.46e-05 | 147 | 84 | 6 | int:FPR1 | |
| Interaction | SLC18A1 interactions | 4.18e-05 | 152 | 84 | 6 | int:SLC18A1 | |
| Interaction | GGT2P interactions | 5.14e-05 | 3 | 84 | 2 | int:GGT2P | |
| Interaction | FFAR1 interactions | 5.66e-05 | 235 | 84 | 7 | int:FFAR1 | |
| Interaction | PTAFR interactions | 6.04e-05 | 51 | 84 | 4 | int:PTAFR | |
| Interaction | ATP2A1 interactions | 6.65e-05 | 423 | 84 | 9 | int:ATP2A1 | |
| Interaction | EBP interactions | 8.15e-05 | 249 | 84 | 7 | int:EBP | |
| Interaction | VSTM1 interactions | 8.75e-05 | 56 | 84 | 4 | int:VSTM1 | |
| Interaction | NAT8B interactions | 8.80e-05 | 21 | 84 | 3 | int:NAT8B | |
| Interaction | P2RY8 interactions | 1.03e-04 | 179 | 84 | 6 | int:P2RY8 | |
| Interaction | S1PR1 interactions | 1.05e-04 | 112 | 84 | 5 | int:S1PR1 | |
| Interaction | ANKRD36B interactions | 1.15e-04 | 60 | 84 | 4 | int:ANKRD36B | |
| Interaction | TSPAN10 interactions | 1.30e-04 | 62 | 84 | 4 | int:TSPAN10 | |
| Interaction | MGST3 interactions | 1.35e-04 | 270 | 84 | 7 | int:MGST3 | |
| Interaction | TSPO2 interactions | 1.39e-04 | 63 | 84 | 4 | int:TSPO2 | |
| Interaction | TSPAN15 interactions | 1.54e-04 | 276 | 84 | 7 | int:TSPAN15 | |
| Interaction | ZDHHC15 interactions | 1.77e-04 | 125 | 84 | 5 | int:ZDHHC15 | |
| Interaction | GPR152 interactions | 1.79e-04 | 198 | 84 | 6 | int:GPR152 | |
| Interaction | EFNA5 interactions | 1.87e-04 | 68 | 84 | 4 | int:EFNA5 | |
| Interaction | TMEM237 interactions | 2.00e-04 | 202 | 84 | 6 | int:TMEM237 | |
| Interaction | TMEM54 interactions | 2.12e-04 | 28 | 84 | 3 | int:TMEM54 | |
| Interaction | CREB3L1 interactions | 2.22e-04 | 206 | 84 | 6 | int:CREB3L1 | |
| Interaction | GPR45 interactions | 2.57e-04 | 300 | 84 | 7 | int:GPR45 | |
| Interaction | S1PR4 interactions | 2.71e-04 | 137 | 84 | 5 | int:S1PR4 | |
| Interaction | LEPROTL1 interactions | 3.02e-04 | 77 | 84 | 4 | int:LEPROTL1 | |
| Interaction | OS9 interactions | 3.09e-04 | 219 | 84 | 6 | int:OS9 | |
| Interaction | CCL4 interactions | 3.18e-04 | 32 | 84 | 3 | int:CCL4 | |
| Interaction | VIT interactions | 3.56e-04 | 7 | 84 | 2 | int:VIT | |
| Interaction | MFSD4A interactions | 3.57e-04 | 225 | 84 | 6 | int:MFSD4A | |
| Interaction | PSCA interactions | 3.75e-04 | 147 | 84 | 5 | int:PSCA | |
| Interaction | CCL4L2 interactions | 3.81e-04 | 34 | 84 | 3 | int:CCL4L2 | |
| Interaction | GLMP interactions | 4.20e-04 | 84 | 84 | 4 | int:GLMP | |
| Interaction | DLK2 interactions | 4.52e-04 | 36 | 84 | 3 | int:DLK2 | |
| Interaction | AQP6 interactions | 4.56e-04 | 330 | 84 | 7 | int:AQP6 | |
| Interaction | C19orf38 interactions | 4.60e-04 | 86 | 84 | 4 | int:C19orf38 | |
| Interaction | CYBC1 interactions | 4.60e-04 | 86 | 84 | 4 | int:CYBC1 | |
| Interaction | GGTLC1 interactions | 4.73e-04 | 8 | 84 | 2 | int:GGTLC1 | |
| Interaction | AQP3 interactions | 4.91e-04 | 239 | 84 | 6 | int:AQP3 | |
| Interaction | TYROBP interactions | 5.02e-04 | 88 | 84 | 4 | int:TYROBP | |
| Interaction | RTP2 interactions | 5.24e-04 | 89 | 84 | 4 | int:RTP2 | |
| Interaction | LMBR1L interactions | GJA1 SLC7A1 VKORC1 HACD3 MARS1 TM9SF1 UQCRQ NUP214 QRICH1 PRKDC HACD2 TNPO3 | 5.34e-04 | 946 | 84 | 12 | int:LMBR1L |
| Interaction | TMEM128 interactions | 5.46e-04 | 90 | 84 | 4 | int:TMEM128 | |
| Cytoband | 2q24 | 1.98e-04 | 11 | 88 | 2 | 2q24 | |
| Cytoband | 6p21.1 | 5.03e-04 | 80 | 88 | 3 | 6p21.1 | |
| GeneFamily | Low density lipoprotein receptors | 8.76e-06 | 13 | 58 | 3 | 634 | |
| GeneFamily | Solute carriers | 2.59e-04 | 395 | 58 | 7 | 752 | |
| GeneFamily | CD molecules|Gamma-glutamyltransferases | 7.71e-04 | 13 | 58 | 2 | 564 | |
| CoexpressionAtlas | MESO-5 blastocyst_vs_MESO-5 bone marrow-Confounder_removed-fold2.0_adjp0.05 | 8.74e-07 | 86 | 80 | 6 | PCBC_ratio_MESO-5 blastocyst_vs_MESO-5 bone marrow_cfr-2X-p05 | |
| CoexpressionAtlas | Mesoderm Day 5_vs_Ectoderm Differentiated Cells-Confounder_removed-fold2.0_adjp0.05 | KDELR3 SLC7A1 SLC7A2 SLC7A3 VANGL1 TSPAN13 UNC93B1 HACD2 ATP12A JMJD1C GALNT18 GGT2P UNC50 GGT1 | 5.21e-06 | 888 | 80 | 14 | PCBC_ratio_MESO-5_vs_ECTO_cfr-2X-p05 |
| CoexpressionAtlas | Mesoderm Day 15_vs_Mesoderm Day 5-Confounder_removed-fold2.0_adjp0.05 | KDELR3 SLC35G1 RNF103 REEP6 GPR157 EGLN1 NQO1 LRP1 LRP2 FADS2 SLC7A7 ALDH5A1 GGT2P GGT1 | 3.37e-05 | 1049 | 80 | 14 | PCBC_ratio_MESO-15_vs_MESO-5_cfr-2X-p05 |
| CoexpressionAtlas | Mesoderm Day 5-reprogram_NA_vs_Mesoderm Day 5-reprogram_OSKM-Confounder_removed-fold2.0_adjp0.05 | 4.75e-05 | 53 | 80 | 4 | PCBC_ratio_MESO-5_from-ESC_vs_MESO-5_from-OSKM_cfr-2X-p05 | |
| CoexpressionAtlas | Mesoderm Day 5-method_NA_vs_Mesoderm Day 5-method_retro-Confounder_removed-fold2.0_adjp0.05 | 4.75e-05 | 53 | 80 | 4 | PCBC_ratio_MESO-5_from-ESC_vs_MESO-5_from-retro_cfr-2X-p05 | |
| CoexpressionAtlas | Mesoderm Day 5-reprogram_NA_vs_Mesoderm Day 5-reprogram_OSKM - NLT-Confounder_removed-fold2.0_adjp0.05 | 1.27e-04 | 68 | 80 | 4 | PCBC_ratio_MESO-5_from-ESC_vs_MESO-5_from-OSKM - NLT_cfr-2X-p05 | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.11e-07 | 145 | 87 | 6 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.88e-07 | 162 | 87 | 6 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-06 | 169 | 87 | 6 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | 10x3'2.3-week_14-16-Myeloid_DC-DC-tDC|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.46e-06 | 180 | 87 | 6 | 3d9f3e6f13e558279b4ef43e2c44c7c50d761745 | |
| ToppCell | droplet-Marrow-nan-18m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.50e-06 | 181 | 87 | 6 | 382337427be3c11ecd03e9fa2c2e831a9674c6a7 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.65e-06 | 184 | 87 | 6 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.65e-06 | 184 | 87 | 6 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.65e-06 | 184 | 87 | 6 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-GAT-Fat-18m-Mesenchymal-mesenchymal_progenitor|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.25e-06 | 194 | 87 | 6 | 9709dc95fb6982b6a0467b507845d5bc17252e3e | |
| ToppCell | facs-GAT-Fat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.25e-06 | 194 | 87 | 6 | 93b7a9065430740ec31fce4e8c14ffccb498591d | |
| ToppCell | facs-GAT-Fat-18m-Mesenchymal|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.25e-06 | 194 | 87 | 6 | 0d2e65b44e3f143971c2fd24c4552f042b049cfa | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Lhx8-Inhibitory_Neuron.Gad1Gad2-Chat_(Nucleus_basalis_(NB))|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 2.87e-06 | 113 | 87 | 5 | 79ba2eb8f85e5da4c19c838df881c18ffdc450fb | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Lhx8|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 2.87e-06 | 113 | 87 | 5 | 91d55fe6fb1c1472867d74461f5b9e4f17db01cd | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Lhx8-Inhibitory_Neuron.Gad1Gad2-Chat_(Nucleus_basalis_(NB))-|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 2.87e-06 | 113 | 87 | 5 | 34ae3dec5ec7585d155ea61de6adc42aa4f45226 | |
| ToppCell | control-Myeloid-CD14_Monocytes_3|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 7.62e-06 | 138 | 87 | 5 | 683cae06f710061d7d74c2f75eb511a2af55bacf | |
| ToppCell | facs-Thymus-nan-3m-Myeloid-macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.97e-05 | 168 | 87 | 5 | d72cd8238fa793bb3e4add4c59eaaaadcea9930d | |
| ToppCell | facs-Thymus-nan-3m-Myeloid-macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.97e-05 | 168 | 87 | 5 | c34c52165485f612add7a3e35a175d5a6e365e7c | |
| ToppCell | facs-Thymus-nan-3m-Myeloid|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.97e-05 | 168 | 87 | 5 | d2afc097ae1243574210be6a751685f949ea941a | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.09e-05 | 170 | 87 | 5 | 5570c0e825bca77613bf0ebde620cf744fa1cb84 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-goblet-BEST2+_Goblet_cell|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.67e-05 | 179 | 87 | 5 | c833ded1f9e87be2ba2037820d92a389560b711c | |
| ToppCell | Neuroendocrine-neuroendo-1|World / Class top | 2.75e-05 | 180 | 87 | 5 | 50fdd182a083380899b5943cb5f55ffd77e2a7d4 | |
| ToppCell | systemic_lupus_erythematosus-treated-Myeloid-plasmacytoid_dendritic_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.90e-05 | 182 | 87 | 5 | 9bbe8062aa562dc3b9c299581faf6ebbcb72a9f7 | |
| ToppCell | systemic_lupus_erythematosus-treated-Myeloid-plasmacytoid_dendritic_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.90e-05 | 182 | 87 | 5 | 4602a98df7045e2c70b7560abfba9b444fbd5d30 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Dendritic-plasmacytoid_dendritic_cell-DC_c4-LILRA4|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.97e-05 | 183 | 87 | 5 | 3b123571e10c132227aff65648b4b3c6acb4bd00 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Dendritic-plasmacytoid_dendritic_cell|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.97e-05 | 183 | 87 | 5 | df6fd0927b6e4cf9a1583969a68096e4bccfbace | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-3m-Epithelial-luminal_epithelial_cell_of_mammary_gland|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.97e-05 | 183 | 87 | 5 | 7eaa6ef7c6cf848fd6489f97677f4406318da22f | |
| ToppCell | 10x5'-bone_marrow-Myeloid_Dendritic-pDC|bone_marrow / Manually curated celltypes from each tissue | 3.05e-05 | 184 | 87 | 5 | 2817d530863e85dfdcd143b7a3dc5fc58a9cd98b | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-24m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.21e-05 | 186 | 87 | 5 | ff6ccfdf2509f96caa10281c29a95b432f6c6dcc | |
| ToppCell | systemic_lupus_erythematosus-flare-Myeloid-plasmacytoid_dendritic_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.21e-05 | 186 | 87 | 5 | a07694caf7fede06a47636725bcc7f09909cdf07 | |
| ToppCell | Multiple_Sclerosis-Myeloid-pDC|Multiple_Sclerosis / Disease, Lineage and Cell Type | 3.21e-05 | 186 | 87 | 5 | 330a4f669adea91ff9f2dff2de2210f5e3401e19 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.21e-05 | 186 | 87 | 5 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | healthy_donor-Lymphocytic-Dendritic|healthy_donor / Disease condition, Lineage, Cell class and subclass | 3.21e-05 | 186 | 87 | 5 | 916f2aeea4989ba7a29e071e348a51010f010223 | |
| ToppCell | healthy_donor-Lymphocytic-Dendritic-pDC|healthy_donor / Disease condition, Lineage, Cell class and subclass | 3.21e-05 | 186 | 87 | 5 | 45f66619e45d590c7365a51782d4ac46b7d31fde | |
| ToppCell | normal_Lung-Myeloid_cells-pDCs|Myeloid_cells / Location, Cell class and cell subclass | 3.30e-05 | 187 | 87 | 5 | a3592f056e1c2f82ba325fea2ecc4dd6c6347c81 | |
| ToppCell | LAM-Lymphoid-pDC|Lymphoid / Condition, Lineage and Cell class | 3.30e-05 | 187 | 87 | 5 | 4d9ffd2bbdf1c9869e28991ce9331e4ccf3c0166 | |
| ToppCell | control-pDC|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.30e-05 | 187 | 87 | 5 | c78aee98b32719aa45811b620fc97be1ecf5fd53 | |
| ToppCell | systemic_lupus_erythematosus-flare-Myeloid-plasmacytoid_dendritic_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.38e-05 | 188 | 87 | 5 | 26405ef1b934744e672c642db78834c21d3ba28f | |
| ToppCell | 3'_v3-lymph-node_spleen-Myeloid_Dendritic-pDC|lymph-node_spleen / Manually curated celltypes from each tissue | 3.47e-05 | 189 | 87 | 5 | 6c2ace61a7d62bcf7e76b73e2da8b722d03e713b | |
| ToppCell | COVID-19_Mild-Myeloid-pDC|COVID-19_Mild / Disease group, lineage and cell class | 3.47e-05 | 189 | 87 | 5 | c6cfd6aa21c19f2c62d80218bbc924e14e82aada | |
| ToppCell | Control-Myeloid-pDC|Control / Disease group, lineage and cell class | 3.47e-05 | 189 | 87 | 5 | 46770b99da42f11f10cfc67cea8562342d60b867 | |
| ToppCell | myeloid-pDC|World / Lineage and Cell class | 3.56e-05 | 190 | 87 | 5 | 88c42779ce2f817d28e672d83f3f1158581edf73 | |
| ToppCell | 3'_v3-bone_marrow-Myeloid_Dendritic-pDC|bone_marrow / Manually curated celltypes from each tissue | 3.56e-05 | 190 | 87 | 5 | dde0e34f6a06cdbbb65c86472360c09f0279a572 | |
| ToppCell | 3'_v3-bone_marrow-Myeloid_Dendritic|bone_marrow / Manually curated celltypes from each tissue | 3.56e-05 | 190 | 87 | 5 | 6892c603037b61ef88d6ca01b7592dc0d347d63b | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.65e-05 | 191 | 87 | 5 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | COVID-19_Moderate-pDC|World / disease group, cell group and cell class | 3.65e-05 | 191 | 87 | 5 | 93adfbc0b22f6006d6d5ad67a99e33cbe9e1dfe9 | |
| ToppCell | systemic_lupus_erythematosus-managed-Myeloid-plasmacytoid_dendritic_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.65e-05 | 191 | 87 | 5 | 8c487704cbbb5eeff54e8c6fb6fffa1472b5351f | |
| ToppCell | COVID-19_Moderate-pDC|COVID-19_Moderate / disease group, cell group and cell class | 3.65e-05 | 191 | 87 | 5 | 9d0ffa65c547e20b4076fd97776d7738cbd453ec | |
| ToppCell | systemic_lupus_erythematosus-managed-Myeloid-plasmacytoid_dendritic_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.65e-05 | 191 | 87 | 5 | 78d523f562d32fc408a20d99b0c61cc103241bc0 | |
| ToppCell | Healthy-pDC|World / disease group, cell group and cell class | 3.65e-05 | 191 | 87 | 5 | 6e1d825dc33b915b95f13ccd237a552160a4be98 | |
| ToppCell | Healthy-pDC|Healthy / disease group, cell group and cell class | 3.74e-05 | 192 | 87 | 5 | 33d695a28d22b4af111df9591830a33bb7ef7b2d | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.74e-05 | 192 | 87 | 5 | deeecd26972241846b4cb998edf0c7a87ff0c4df | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.83e-05 | 193 | 87 | 5 | 294cb5b580bb83fe0eb04f112d5507aac35d4d44 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.83e-05 | 193 | 87 | 5 | 3d3c45d5ff6f3396a1990615aae9fe176e799994 | |
| ToppCell | control-pDC|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.83e-05 | 193 | 87 | 5 | 30a6559c9a9e8941861cb259b4836acccc427e68 | |
| ToppCell | 10x5'-Lung-Myeloid_Dendritic|Lung / Manually curated celltypes from each tissue | 3.83e-05 | 193 | 87 | 5 | 7bce609699c515d2d114596a0c527f90cc09c4af | |
| ToppCell | normal-na-Myeloid-plasmacytoid_dendritic_cell-female|normal / PBMC cell types (v2) per disease, treatment status, and sex | 3.93e-05 | 194 | 87 | 5 | 74545942aded51a0f4ee96054b4ce12c4d99a8a0 | |
| ToppCell | normal-na-Myeloid-plasmacytoid_dendritic_cell|normal / PBMC cell types (v2) per disease, treatment status, and sex | 3.93e-05 | 194 | 87 | 5 | c25fc353001cdf9fcd772da5a254c857e555eab8 | |
| ToppCell | 10x5'-bone_marrow-Myeloid_Dendritic|bone_marrow / Manually curated celltypes from each tissue | 3.93e-05 | 194 | 87 | 5 | 768271ae45ff9f6aa3cd9b0ed15fa3caaa68a7b0 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c5-CD16|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.94e-05 | 97 | 87 | 4 | 332b4daf5106872dd891d9f9b5a891192d5d9aa8 | |
| ToppCell | control-CD163+_Monocytes_(Sample_ID1_d7)|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.02e-05 | 195 | 87 | 5 | 19413dc6aa0010686cdfa0c750ef0a7a76caf308 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.12e-05 | 196 | 87 | 5 | 525d6c8a277364e624e7cc586275f8a891436b57 | |
| ToppCell | Tracheal-10x5prime-Stromal-Schwann|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.12e-05 | 196 | 87 | 5 | b6226163d9fc93ecfff2115bb74408303a000490 | |
| ToppCell | distal-Epithelial-Alveolar_Epithelial_Type_2-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.33e-05 | 198 | 87 | 5 | 19eefd05573fbaed654af52bf0f8a26092b8b229 | |
| ToppCell | medial-2-Epithelial-Alveolar_Epithelial_Type_2|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.33e-05 | 198 | 87 | 5 | 102a4cbb138adbfba11ed955420095daa098532f | |
| ToppCell | severe-pDC|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.33e-05 | 198 | 87 | 5 | 22da4a29b9ff8b94d98bc69b4632a2a58d5dd9e6 | |
| ToppCell | medial-Epithelial-Alveolar_Epithelial_Type_2-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.33e-05 | 198 | 87 | 5 | 7caeed2d5dc78866023c8f38edcec9886baa9f2c | |
| ToppCell | severe-pDC|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.33e-05 | 198 | 87 | 5 | 3c4820a8391088682fb3e47b914f872533bae227 | |
| ToppCell | medial-Epithelial-Alveolar_Epithelial_Type_2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.33e-05 | 198 | 87 | 5 | 53e5d76831d70b9a476f3ef3a81e13eda974d543 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.43e-05 | 199 | 87 | 5 | 8b86c69aaf60feff53aa782559cfece7342a23de | |
| ToppCell | LPS_only-Endothelial-Endothelial-Vein|LPS_only / Treatment groups by lineage, cell group, cell type | 4.54e-05 | 200 | 87 | 5 | b036f5e22c95a3b14391785b6e91aa183b9bc9a8 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.54e-05 | 200 | 87 | 5 | 07d942803360e1a1e8e131d6e31c726dd0db1a0b | |
| ToppCell | (54)_pDC|World / shred on Cell_type and subtype | 4.87e-05 | 203 | 87 | 5 | b8ba3e51770ff7b45cd02472f3e63aa4d5816f6f | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c4-CD14-CD16|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.46e-05 | 118 | 87 | 4 | 7e6cb77fa9154f2da985c455bb6a24d6029cc8d6 | |
| ToppCell | TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Classical-6|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 1.30e-04 | 132 | 87 | 4 | b7611c6a5c86908132e7ab3e41d67277e8142db1 | |
| ToppCell | facs-MAT-Fat-18m-Epithelial-nan|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.82e-04 | 144 | 87 | 4 | 65ffd8a1620b178d995fe8c913871f0b376b896f | |
| ToppCell | facs-MAT-Fat-18m-Epithelial-epithelial_cell|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.82e-04 | 144 | 87 | 4 | fd852095dcd716ac53b0fd25d83e6f454b2ae794 | |
| ToppCell | LPS-IL1RA-Myeloid-Monocytes,_Macrophages-Erythroid|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.82e-04 | 144 | 87 | 4 | 7c471e332f87d60f4dbed01f3e66bf39995218d0 | |
| ToppCell | facs-MAT-Fat-18m-Epithelial|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.82e-04 | 144 | 87 | 4 | e4e148007c772cd163a34fb172e05184f7352a2b | |
| ToppCell | PND03-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD8_T-CD8_T_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.87e-04 | 145 | 87 | 4 | a9f5a32abcf3eb2c66bd65f2521a6dd4ce56c635 | |
| ToppCell | E18.5-samps-Mesenchymal-Myofibroblast-MyoFB-1|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.87e-04 | 145 | 87 | 4 | ac41c6c02b7d78162b86222983688f54d04ac47d | |
| ToppCell | PND07-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.92e-04 | 146 | 87 | 4 | 45d7cb73776e60d22f335a651845e21e16948fcc | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c06-TNF|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.08e-04 | 149 | 87 | 4 | 3378d0fe79de6d7879fd48717ded5027593c785f | |
| ToppCell | Goblet|World / Class top | 2.54e-04 | 157 | 87 | 4 | b352aa37d662629db6a9c6def9ee6d7c49a9071c | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.66e-04 | 159 | 87 | 4 | 7747cef94c55144fddcd024a7495318357f1351b | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Mesenchymal|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 2.66e-04 | 159 | 87 | 4 | f34f2729a3872fbb2939e76ad35d7e25f71b8f57 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Mesenchymal-Unfolded_protein_responsible_cell|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 2.66e-04 | 159 | 87 | 4 | 929ed98f6c2ad14e8d5af5c6f11a5a3d4b388cf7 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.73e-04 | 160 | 87 | 4 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.73e-04 | 160 | 87 | 4 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligodendroglioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 2.79e-04 | 161 | 87 | 4 | 5f6b2d7f80a8ee16651e304481d2da3fae313824 | |
| ToppCell | facs-Marrow-KLS-24m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.86e-04 | 162 | 87 | 4 | 860ebf2390b4ad86475ad54717cbefcf61cd3b2a | |
| ToppCell | facs-Marrow-KLS-24m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.86e-04 | 162 | 87 | 4 | 14e9f8aaba308619eb9da90796c336e76cedac1f | |
| ToppCell | Influenza_Severe-pDC|World / Disease group and Cell class | 3.13e-04 | 166 | 87 | 4 | bd25ce4c03c3d6cd9d986b9be1d355da52f0f2d7 | |
| ToppCell | Influenza_Severe-pDC|Influenza_Severe / Disease group and Cell class | 3.13e-04 | 166 | 87 | 4 | b43a5cd4d28118cf6e56a435deb8ea9435608a90 | |
| ToppCell | facs-Heart-RV-24m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.21e-04 | 167 | 87 | 4 | 3e3d8f6df2feefafad5b44ba0ebf5b5a0fe4ed58 | |
| ToppCell | facs-Heart-RV-24m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.21e-04 | 167 | 87 | 4 | 3ad9f3122dbe96580f640388ef920ea209fc2349 | |
| ToppCell | facs-Spleen-nan-24m-Hematologic-proerythroblast|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.21e-04 | 167 | 87 | 4 | 16bb7293fc8ca582b7cb4450917aff07b34fc70a | |
| ToppCell | facs-Spleen-nan-24m-Hematologic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.21e-04 | 167 | 87 | 4 | 515988c7035c550a2f072430d9d7027869593d17 | |
| ToppCell | facs-Marrow-Granulocytes-18m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.21e-04 | 167 | 87 | 4 | 528493896aebe7d03d4b6ad2341b12927859e2e4 | |
| ToppCell | facs-Marrow-Granulocytes-18m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.21e-04 | 167 | 87 | 4 | a82e85caf79395baa48380786d9df32a86dfd1ce | |
| ToppCell | facs-Spleen-nan-24m-Hematologic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.21e-04 | 167 | 87 | 4 | f12d00e6c600b0bba3e4e1b1c80b791e095de931 | |
| Drug | L-Lysine | 5.17e-07 | 5 | 86 | 3 | DB00123 | |
| Drug | dl-ornithine | 5.70e-07 | 188 | 86 | 8 | CID000000389 | |
| Drug | potassium | SLC7A1 SLC7A2 SLC7A3 KCNC1 SLC24A2 SCN7A SCN9A GABRQ SV2C ATP12A KCNK17 SSTR2 SLC7A7 CNGA2 GGT1 RYR2 | 1.01e-06 | 1008 | 86 | 16 | CID000000813 |
| Drug | sodium | SLC7A1 SLC7A2 SLC7A3 MCHR1 KCNC1 SLC24A2 SCN7A SCN9A NQO1 LRP2 ABCB11 GABRQ ATP12A SLC7A7 RYR2 | 2.28e-06 | 944 | 86 | 15 | CID000000923 |
| Drug | L-Ornithine | 1.84e-05 | 14 | 86 | 3 | DB00129 | |
| Drug | DL-ethionine | 1.98e-05 | 87 | 86 | 5 | CID000006205 | |
| Disease | epilepsy (implicated_via_orthology) | 4.37e-07 | 163 | 84 | 7 | DOID:1826 (implicated_via_orthology) | |
| Disease | Prostatic Neoplasms | JAK2 GJA1 SLC7A1 NQO1 LRP2 NOX3 ALOXE3 PRKDC LRP1B ST14 GGT1 | 1.40e-06 | 616 | 84 | 11 | C0033578 |
| Disease | Malignant neoplasm of prostate | JAK2 GJA1 SLC7A1 NQO1 LRP2 NOX3 ALOXE3 PRKDC LRP1B ST14 GGT1 | 1.40e-06 | 616 | 84 | 11 | C0376358 |
| Disease | Hemorrhage | 2.45e-05 | 20 | 84 | 3 | C0019080 | |
| Disease | overactive bladder syndrome (biomarker_via_orthology) | 4.79e-05 | 4 | 84 | 2 | DOID:0070355 (biomarker_via_orthology) | |
| Disease | Autism Spectrum Disorders | 1.04e-04 | 85 | 84 | 4 | C1510586 | |
| Disease | Familial erythrocytosis | 1.19e-04 | 6 | 84 | 2 | cv:C0152264 | |
| Disease | non-alcoholic fatty liver disease (implicated_via_orthology) | 1.48e-04 | 36 | 84 | 3 | DOID:0080208 (implicated_via_orthology) | |
| Disease | aflatoxins-related hepatocellular carcinoma (biomarker_via_orthology) | 1.67e-04 | 7 | 84 | 2 | DOID:5022 (biomarker_via_orthology) | |
| Disease | alcohol dependence (biomarker_via_orthology) | 2.22e-04 | 8 | 84 | 2 | DOID:0050741 (biomarker_via_orthology) | |
| Disease | Polycythemia | 2.22e-04 | 8 | 84 | 2 | C0032461 | |
| Disease | Pruritus | 2.22e-04 | 8 | 84 | 2 | C0033774 | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 3.55e-04 | 10 | 84 | 2 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 3.55e-04 | 10 | 84 | 2 | DOID:0080422 (implicated_via_orthology) | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 5.19e-04 | 12 | 84 | 2 | DOID:0060170 (implicated_via_orthology) | |
| Disease | brain disease (is_implicated_in) | 5.19e-04 | 12 | 84 | 2 | DOID:936 (is_implicated_in) | |
| Disease | hepcidin:ferritin ratio | 5.25e-04 | 55 | 84 | 3 | EFO_0007901 | |
| Disease | kynurenic acid measurement | 6.12e-04 | 13 | 84 | 2 | EFO_0010506 | |
| Disease | Migraine Disorders | 6.12e-04 | 13 | 84 | 2 | C0149931 | |
| Disease | Paraganglioma | 6.12e-04 | 13 | 84 | 2 | C0030421 | |
| Disease | leukemia (is_implicated_in) | 6.12e-04 | 13 | 84 | 2 | DOID:1240 (is_implicated_in) | |
| Disease | adverse effect, response to xenobiotic stimulus | 6.45e-04 | 59 | 84 | 3 | EFO_0009658, GO_0009410 | |
| Disease | Precursor Cell Lymphoblastic Leukemia Lymphoma | 7.11e-04 | 61 | 84 | 3 | C1961102 | |
| Disease | triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement | 9.03e-04 | 150 | 84 | 4 | EFO_0004611, EFO_0020947 | |
| Disease | Acute myeloid leukemia | 1.06e-03 | 17 | 84 | 2 | cv:C0023467 | |
| Disease | Familial Progressive Myoclonic Epilepsy | 1.06e-03 | 17 | 84 | 2 | C0751777 | |
| Disease | Atypical Inclusion-Body Disease | 1.06e-03 | 17 | 84 | 2 | C0751776 | |
| Disease | Myoclonic Epilepsies, Progressive | 1.06e-03 | 17 | 84 | 2 | C0751778 | |
| Disease | LEUKEMIA, ACUTE MYELOID | 1.06e-03 | 17 | 84 | 2 | 601626 | |
| Disease | Biotin-Responsive Encephalopathy | 1.06e-03 | 17 | 84 | 2 | C0751780 | |
| Disease | May-White Syndrome | 1.06e-03 | 17 | 84 | 2 | C0751782 | |
| Disease | Dentatorubral-Pallidoluysian Atrophy | 1.06e-03 | 17 | 84 | 2 | C0751781 | |
| Disease | spine bone size | 1.19e-03 | 18 | 84 | 2 | EFO_0004508 | |
| Disease | Action Myoclonus-Renal Failure Syndrome | 1.19e-03 | 18 | 84 | 2 | C0751779 | |
| Disease | acute myeloid leukemia (is_implicated_in) | 1.80e-03 | 84 | 84 | 3 | DOID:9119 (is_implicated_in) | |
| Disease | liver fibrosis measurement | 1.92e-03 | 86 | 84 | 3 | EFO_0010576 | |
| Disease | serum iron measurement | 1.92e-03 | 86 | 84 | 3 | EFO_0006332 | |
| Disease | cholelithiasis | 2.05e-03 | 88 | 84 | 3 | EFO_0004799 | |
| Disease | omega-6 polyunsaturated fatty acid measurement | 2.45e-03 | 197 | 84 | 4 | EFO_0005680 | |
| Disease | low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 2.59e-03 | 200 | 84 | 4 | EFO_0004611, EFO_0020945 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FVVSYWLFYGVRILD | 196 | Q8TAA9 | |
| EFLEATYFISYWEDE | 146 | P61568 | |
| FTYYTAWVILLPFID | 21 | O94777 | |
| FWYGSTLVLDEGEYT | 341 | O95342 | |
| IWKNYYAESYGVIFV | 81 | Q3SXY8 | |
| GREVDWEYFYGLLFT | 281 | O76075 | |
| LYTYVTVGELWAFIT | 101 | P52569 | |
| PQFVVFYLIYTWGTE | 51 | O14949 | |
| FYLIYTWGTEEFERS | 56 | O14949 | |
| DDIFSDLYYVRFTEW | 566 | Q2TAL8 | |
| DVWSFGVVLYELFTY | 1036 | O60674 | |
| FIFETGYWLTNAIKY | 261 | Q7Z5J8 | |
| IALESIAWFTVFYFG | 141 | O95864 | |
| GTFLSLAVYDNYIFW | 2406 | Q9NZR2 | |
| IAIDFDYREEFIYWI | 3046 | Q9NZR2 | |
| GVIALTLFEDYIYWT | 3216 | Q9NZR2 | |
| LAVDYFSERIYWADF | 4076 | Q9NZR2 | |
| YWADFELSIIGSVLY | 4086 | Q9NZR2 | |
| FVFYLWSAIEIFRYS | 246 | Q9P035 | |
| TEILYLTVAYDWFLF | 361 | Q8NCE2 | |
| AWSSVDLGDYYVVFV | 306 | Q5VTL7 | |
| VESYGYTVEDIILFW | 201 | Q9UN88 | |
| WAAIESFVSEIVGYY | 516 | Q9BYJ1 | |
| VYWADAYLDYIEVVD | 381 | Q07954 | |
| REYLEWTGYTAFFVG | 926 | P54707 | |
| WVKVYEDFSTFLVEY | 71 | Q15652 | |
| TSLDVFLRWLFDIYY | 511 | Q9P1W3 | |
| YSFTLLEILWTFSIY | 111 | O43731 | |
| WSYTEGFYFAFITLS | 206 | Q96T54 | |
| TWVYEYTVFLSSTIF | 191 | Q8NG80 | |
| VWVSFFEIYNEYIYD | 271 | Q96Q89 | |
| VLWIGTYVFAIVYAA | 246 | P35658 | |
| DVYSGYLLWEALVYS | 266 | Q8TDT2 | |
| VYWVDSRFDYIETVT | 571 | P98164 | |
| EAVYVLGTYLWTDVY | 16 | Q9Y2J8 | |
| WFERVFIGEFAYTYA | 116 | P15559 | |
| YFIAWITFIPIYATT | 791 | Q5T6X5 | |
| LTYWVVYALFGLAEF | 86 | Q96HR9 | |
| TYIEGVCVVWFTFEF | 246 | P48547 | |
| EEFFIPYVWSLVYNS | 636 | Q7RTS9 | |
| VTLWIFYDTGYTERY | 781 | Q6V1X1 | |
| WTITEIIRYSFYTFS | 141 | Q6Y1H2 | |
| EVAFLLIQWYIYGFS | 166 | P17302 | |
| LLYVGWVTNYIASVY | 26 | Q6P9A2 | |
| TSSFFWTVAIALYLY | 91 | Q5UAW9 | |
| VDAVVYGILTWYIEA | 901 | Q9BZC7 | |
| ATRYAITVWYFDADE | 381 | Q9GZT9 | |
| DTDLYWFTLYQFFLA | 271 | Q99705 | |
| ETVSEYGVLIFIYGW | 16 | Q4VXA5 | |
| ADYSYWTLGYVISLE | 491 | Q8IYK4 | |
| IGGDYFFIYAWLFTL | 191 | O75844 | |
| FFEAIVWYETGIFAT | 21 | O00237 | |
| GVVFTDNSFLYLAWY | 4711 | Q92736 | |
| SAYLYSYVTVGELWA | 96 | Q8WY07 | |
| TALAIIYNLWFGYDV | 481 | P36268 | |
| TVVAIFYGTLSWVYF | 246 | Q15612 | |
| ASGNLIEYISYFWVI | 76 | Q9NYW0 | |
| GYTYYVWFVIFLASV | 241 | P78382 | |
| EILYSAFFLEWFSEE | 156 | P51649 | |
| LTIVWFTLSFGYYGL | 436 | Q496J9 | |
| ITFFGSITWIAVFSY | 501 | Q9UI40 | |
| IGFYIYESIEYWNTS | 556 | Q96NR3 | |
| GFVRISWFESYLNYL | 581 | Q96NR3 | |
| WTKNVEYTFTGIYTF | 151 | Q15858 | |
| LFIDTFYWYEEEESF | 26 | Q9HBY0 | |
| STEFIRQASYELFWY | 191 | Q9HBY0 | |
| SGAWYTGFIIYTFIL | 201 | P30874 | |
| EYFTWAGFKDYNLVV | 356 | Q9Y471 | |
| YWYLVTEGQIFILFI | 221 | Q9NWW5 | |
| YYLVWLVLDYVSDVV | 171 | Q16280 | |
| WIYIFDVVDGTYVAH | 221 | Q96JI7 | |
| VIAVDWIYGSTGVYF | 116 | Q53H76 | |
| TLWLVAVGYYIYVTF | 196 | Q53HI1 | |
| LAVGIYALFVSTNYW | 141 | Q9H1C4 | |
| TFLWEVVGYVEGLFF | 1956 | Q8N2C7 | |
| FSFTEILGVWLTYRY | 176 | O95857 | |
| GSVYLAWILFFVLYD | 116 | Q9BQB6 | |
| WILGDVFLRSYYSVY | 361 | P20142 | |
| IWISFFEIYNELLYD | 301 | O95235 | |
| SAYLYSYVTVGELWA | 96 | P30825 | |
| YVKWGTLVQDIFTYA | 176 | Q9UM01 | |
| FSEGSVIAYYWSEFS | 146 | Q9Y5Y6 | |
| FESFYTFCTYVAWIV | 236 | Q96LQ0 | |
| FFEPWVYSFSYELIL | 641 | P78527 | |
| YEVVEISFNFWYRLG | 336 | Q9Y5L0 | |
| TAIYSVVGYASYLVW | 51 | Q5TGU0 | |
| GKSVDYFLSIWYYVV | 246 | Q2M3R5 | |
| YFLSIWYYVVLGLVE | 251 | Q2M3R5 | |
| VGIFYFVSYILISWL | 1471 | Q01118 | |
| RFYIYLGFAVSISLW | 21 | Q9NV66 | |
| FRGLVIYIVWIFFYE | 91 | Q8N7C4 | |
| EDKVFYVWFDATIGY | 511 | P56192 | |
| YVWFDATIGYLSITA | 516 | P56192 | |
| RFYIYLGFAVSISLW | 21 | Q6NUM6 | |
| SAISVELYYIFATVW | 476 | O15321 | |
| ELYYIFATVWGREQY | 481 | O15321 | |
| TALAIIYNLWFGYDV | 481 | P19440 | |
| RLSDGFTFVIYEFWE | 326 | Q7Z6G3 |